By Matthew Heller ( October 30, 2013, 10:12 PM EDT) -- Genentech Inc. on Wednesday urged a California federal judge to trim a suit seeking to invalidate its patents for a blood cancer treatment, saying Eli Lilly and Co. had failed to show a Genentech attorney and others engaged in inequitable conduct in prosecuting the patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.